Comparative outcomes of cardioplegic arrest versus beating heart in pediatric undergoing extracardiac total cavopulmonary connection.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
08 Oct 2024
Historique:
received: 05 08 2024
accepted: 19 09 2024
medline: 9 10 2024
pubmed: 9 10 2024
entrez: 8 10 2024
Statut: epublish

Résumé

Total cavopulmonary connection (TCPC) is a definitive palliative procedure for functionally univentricular congenital heart disease. The study aims to compare the impact of on-pump cardioplegic arrest and on-pump beating heart cardiopulmonary bypass (CPB) on the prognosis of pediatric patients undergoing extracardiac TCPC. The medical data of patients (< 18 years) who underwent extracardiac TCPC with CPB between January 2008 and December 2020 in the cardiac surgery center were retrospectively analyzed. Depending on CPB strategies, the patients were assigned to the beating-heart (BH) and cardioplegic arrest (CA) groups. Data including baseline characteristics, intra/postoperative variables, and clinical outcomes were collected for analysis with 1:1 propensity score matching and multivariable stepwise logistic regressions. Fifty-seven matched patient pairs were obtained. No significant difference existed between the two groups in the in-hospital mortality (3.5% vs. 1.8%, P = 1) and one-year survival rate (100% vs. 96.4%, P = 0.484). The BH group had significantly less intraoperative platelet transfusion (10 mL vs. 150 mL, P = 0.019) and blood loss (100 mL vs. 150 mL, P = 0.033) than the CA group. The CA group had significantly higher vasoactive-inotropic scores (P < 0.05) and longer postoperative ICU stays (2.0 d vs. 3.7 d, P = 0.017). No significant difference existed between the two groups in the incidence of postoperative adverse events. Although both CPB strategies are safe and feasible for extracardiac TCPC, the BH technique would cause less intraoperative platelet transfusion and blood loss, and achieve faster early-term postoperative recovery.

Sections du résumé

BACKGROUND BACKGROUND
Total cavopulmonary connection (TCPC) is a definitive palliative procedure for functionally univentricular congenital heart disease. The study aims to compare the impact of on-pump cardioplegic arrest and on-pump beating heart cardiopulmonary bypass (CPB) on the prognosis of pediatric patients undergoing extracardiac TCPC.
METHODS METHODS
The medical data of patients (< 18 years) who underwent extracardiac TCPC with CPB between January 2008 and December 2020 in the cardiac surgery center were retrospectively analyzed. Depending on CPB strategies, the patients were assigned to the beating-heart (BH) and cardioplegic arrest (CA) groups. Data including baseline characteristics, intra/postoperative variables, and clinical outcomes were collected for analysis with 1:1 propensity score matching and multivariable stepwise logistic regressions.
RESULTS RESULTS
Fifty-seven matched patient pairs were obtained. No significant difference existed between the two groups in the in-hospital mortality (3.5% vs. 1.8%, P = 1) and one-year survival rate (100% vs. 96.4%, P = 0.484). The BH group had significantly less intraoperative platelet transfusion (10 mL vs. 150 mL, P = 0.019) and blood loss (100 mL vs. 150 mL, P = 0.033) than the CA group. The CA group had significantly higher vasoactive-inotropic scores (P < 0.05) and longer postoperative ICU stays (2.0 d vs. 3.7 d, P = 0.017). No significant difference existed between the two groups in the incidence of postoperative adverse events.
CONCLUSION CONCLUSIONS
Although both CPB strategies are safe and feasible for extracardiac TCPC, the BH technique would cause less intraoperative platelet transfusion and blood loss, and achieve faster early-term postoperative recovery.

Identifiants

pubmed: 39379803
doi: 10.1186/s12872-024-04210-5
pii: 10.1186/s12872-024-04210-5
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

540

Subventions

Organisme : The National Natural Science Fundation of China
ID : 81960669
Organisme : The National High Level Hospital Clinical Research Funding
ID : 2022-GSP-GG-22

Informations de copyright

© 2024. The Author(s).

Références

Idorn L, Olsen M, Jensen AS, Juul K, Reimers JI, Sørensen K, et al. Univentricular hearts in Denmark 1977 to 2009: incidence and survival. Int J Cardiol. 2013;167(4):1311–6.
doi: 10.1016/j.ijcard.2012.03.182 pubmed: 22521378
Hirose K, Ikai A, Murata M, Ito H, Koshiyama H, Ishidou M, et al. Intra-extracardiac total cavopulmonary connection for patients with anatomical complexity. Ann Thorac Surg. 2021;111(3):958–65.
doi: 10.1016/j.athoracsur.2020.05.176 pubmed: 32763269
Chaloupecký V, Jičínská D, Tomek V, Materna O, Gebauer R, Poruban R, et al. Impact of liver fibrosis and nodules formation on hemodynamics in young adults after total cavopulmonary connection. A magnetic resonance study. Front Cardiovasc Med. 2022;9:986653.
doi: 10.3389/fcvm.2022.986653 pubmed: 36247450 pmcid: 9558211
Ovroutski S, Sohn C, Barikbin P, Miera O, Alexi-Meskishvili V, Hubler M, et al. Analysis of the risk factors for early failure after extracardiac Fontan operation. Ann Thorac Surg. 2013;95:1409–16.
doi: 10.1016/j.athoracsur.2012.12.042 pubmed: 23453748
Ovroutski S, Sohn C, Miera O, Peters B, Alexi-Meskishvili V, Hetzer R, et al. Improved early postoperative outcome for extracardiac Fontan operation without cardiopulmonary bypass: a single-centre experience. EurJ Cardiothorac Surg. 2013;43:952–7.
doi: 10.1093/ejcts/ezs535
Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753–79.
doi: 10.1016/j.kint.2021.05.015 pubmed: 34556300
Belletti A, Lerose CC, Zangrillo A, Landoni G. Vasoactive-inotropic score: evolution, clinical utility, and pitfalls. J Cardiothorac Vasc Anesth. 2021;35(10):3067–77.
doi: 10.1053/j.jvca.2020.09.117 pubmed: 33069558
Poncelet AJ, van Steenberghe M, Moniotte S, Detaille T, Beauloye C, Bertrand L, et al. Cardiac and neurological assessment of normothermia/warm blood cardioplegia vs. hypothermia/cold crystalloid cardioplegia in pediatric cardiac surgery: insight from a prospective randomized trial. Eur J Cardiothorac Surg. 2011;40(6):1384–90.
doi: 10.1016/j.ejcts.2011.03.047 pubmed: 21752665
Caputo M, Pike K, Baos S, Sheehan K, Selway K, Ellis L, et al. Normothermic versus hypothermic cardiopulmonary bypass in low-risk paediatric heart surgery: a randomised controlled trial. Heart. 2019;105(6):455–64.
doi: 10.1136/heartjnl-2018-313567 pubmed: 30322847
Ueki C, Sakaguchi G, Akimoto T, Ohashi Y, Sato H. On-pump beating-heart technique is associated with lower morbidity and mortality following coronary artery bypass grafting: a meta-analysis. Eur J Cardiothorac Surg. 2016;50(5):813–21.
doi: 10.1093/ejcts/ezw129 pubmed: 27107048
Bartoszko J, Karkouti K. Managing the coagulopathy associated with cardiopulmonary bypass. J Thromb Haemost. 2021;19(3):617–32.
doi: 10.1111/jth.15195 pubmed: 33251719
Jung KT, Bapat A, Kim YK, Hucker WJ, Lee K. Therapeutic hypothermia for acute myocardial infarction: a narrative review of evidence from animal and clinical studies. Korean J Anesthesiol. 2022;75(3):216–30.
doi: 10.4097/kja.22156 pubmed: 35350095 pmcid: 9171548
Shah M, Parikh K, Patel B, Agarwal M, Garg L, Agrawal S, et al. Use of therapeutic hypothermia among patients with coagulation disorders — a nationwide analysis. Resuscitation. 2018;124:35–42.
doi: 10.1016/j.resuscitation.2018.01.005 pubmed: 29305925
Mitrophanov AY, Szlam F, Sniecinski RM, Levy JH, Reifman J. Controlled multifactorial coagulopathy: effects of dilution, hypothermia, and acidosis on thrombin generation in vitro. Anesth Analg. 2020;130(4):1063–76.
doi: 10.1213/ANE.0000000000004479 pubmed: 31609256
Tong Y, Zhang P, Li S, Yan J, Feng Z, Zhao J, et al. Perioperative blood product transfusion of two different perfusion strategies on pediatric patients undergoing aortic arch surgery. Artif Organs. 2020;44(1):40–9.
doi: 10.1111/aor.13539 pubmed: 31315148
Hvas AM, Andreasen JB, Christiansen K, Ravn HB. Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery. Blood Coagul Fibrinolysis. 2013;24(6):587–92.
doi: 10.1097/MBC.0b013e32836029d2 pubmed: 23571685
Bønding Andreasen J, Hvas AM, Ravn HB. Marked changes in platelet count and function following pediatric congenital heart surgery. Paediatr Anaesth. 2014;24(4):386–92.
doi: 10.1111/pan.12347 pubmed: 24471808
Van Poucke S, Stevens K, Marcus AE, Lancé M. Hypothermia: effects on platelet function and hemostasis. Thromb J. 2014;12(1):31.
doi: 10.1186/s12959-014-0031-z pubmed: 25506269 pmcid: 4265340
Deshaies C, Hamilton RM, Shohoudi A, Trottier H, Poirier N, Aboulhosn J, et al. Thromboembolic risk after Atriopulmonary, lateral tunnel, and Extracardiac Conduit Fontan surgery. J Am Coll Cardiol. 2019;74(8):1071–81.
doi: 10.1016/j.jacc.2019.06.051 pubmed: 31439217
Govindapillai A, Hancock Friesen C, O’Blenes SB. Protecting the aged heart during cardiac surgery: single-dose Del Nido Cardioplegia is superior to multi-dose del nido cardioplegia in isolated rat hearts. Perfusion. 2016;31(2):135–42.
doi: 10.1177/0267659115588633 pubmed: 26034195
Zakkar M, Guida G, Suleiman MS, Angelini GD. Cardiopulmonary bypass and oxidative stress. Oxid Med Cell Longev. 2015;2015:189863.
doi: 10.1155/2015/189863 pubmed: 25722792 pmcid: 4334937
Du X, Chen H, Song X, Wang S, Hao Z, Yin L, et al. Risk factors for low cardiac output syndrome in children with congenital heart disease undergoing cardiac surgery: a retrospective cohort study. BMC Pediatr. 2020;20(1):87.
doi: 10.1186/s12887-020-1972-y pubmed: 32093619 pmcid: 7038550
Kim G, Ko H, Byun JH, Lee HD, Kim H, Sung SC, et al. Risk factors for prolonged pleural effusion after extracardiac Fontan operation. Pediatr Cardiol. 2019;40(8):1545–52.
doi: 10.1007/s00246-019-02183-3 pubmed: 31435694
Bai L, Feng Z, Zhao J, Guo S, Tong Y, Jin Y, et al. Risk factors and long-term prognosis for chylothorax after total cavopulmonary connection in children: a retrospective study from a single center. Front Pediatr. 2021;9:744019.
doi: 10.3389/fped.2021.744019 pubmed: 34869101 pmcid: 8637757

Auteurs

Wenting Wang (W)

Department of Anesthesiology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167, North Lishi Road, Xicheng District, Beijing, 100037, China.

Peiyao Zhang (P)

Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

Yu Jin (Y)

Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167, North Lishi Road, Xicheng District, Beijing, 100037, China.

Jia Liu (J)

Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167, North Lishi Road, Xicheng District, Beijing, 100037, China.

He Wang (H)

Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167, North Lishi Road, Xicheng District, Beijing, 100037, China.

Jinping Liu (J)

Department of Cardiopulmonary Bypass, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, No.167, North Lishi Road, Xicheng District, Beijing, 100037, China. liujinping@fuwai.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH